Agile Therapeutics, Inc Earning Date (AGRX)

USA |NASDAQ |USD

AGRX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Feb 28, 2022 Dec 2021 $-0.17 - $-0.20
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Feb 28, 2022 Dec 2021 $2.02M - $749.00K

Agile Therapeutics, Inc's next earnings date is Monday, Feb 28, 2022 for the fiscal quarter ending Dec 2021.

AGRX Earnings Date & History Chart

AGRX Earnings & Revenue Forecast

AGRX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.17 $-0.23 $-0.14
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $-0.76 $-0.87 $-0.69
Dec 2022 4 $-0.59 $-0.93 $-0.39

AGRX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-0.18 $-0.17 $-0.15
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 0 $-0.77 $-0.76 $-0.75
Dec 2022 0 / 1 $-0.55 $-0.41 $-0.30

AGRX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 4 $2.02M $1.80M $2.41M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 4 $4.78M $4.49M $5.22M
Dec 2022 4 $26.09M $23.50M $28.59M

AGRX Earnings Date & Revenue History

AGRX Earnings History

|
Show More
Show More

AGRX Revenue History

|
Show More
Show More

Agile Therapeutics, Inc Next Earnings Date & Report

AGRX Next Earnings Date & Report Preview: Dec 2021 (FQ)

AGRX's next earnings date is Monday, Feb 28, 2022 for the fiscal quarter ending Dec 31, 2021.

According to analysts, the average EPS estimation for Agile Therapeutics, Inc's next quarterly earnings is $-0.17, with a low EPS estimation of $-0.23, and a high estimation of $-0.14.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.18, the last 2 month trend is $-0.17, and the 3 month trend is $-0.15.

Based on analysts, the average revenue estimation is $2.02M, with a low revenue estimation of $1.80M, and a high estimation of $2.41M.

Agile Therapeutics, Inc Previous Earnings Dates & Reports

AGRX Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Agile Therapeutics, Inc's previous earnings date was Nov 2, 2021 for its fiscal quarter ended Sep 30, 2021.

AGRX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Agile Therapeutics, Inc's previous annual earnings date was Mar 1, 2021 for its fiscal year ended Dec 31, 2020.

AGRX's earnings per share (EPS) was $-0.60, beating the consensus analysts forecast of $-0.64 by -6.25% , and lower than the previous year's EPS (Dec 2019) by 53.85%.

Revenues were $749.00K.

The company reported a net income of $-51.85M.

Agile Therapeutics, Inc reported a free cash flow of $-47.66M for its fiscal year, compared to $-15.79M a year ago.

The company ended the fiscal year with $16.52M in total debt, an increase of 9504.07% compared to the previous year.